Noninvasive monitoring using serum amyloid A and serum neopterin in cardiac transplantation

Clinica Chimica Acta

Volumn 276, Issue 1, 1998, Pages 63-74

  Müller, Thomas F ^a   Vogl, Mariette ^b   Neumann, Maria C ^a   Lange, Harald ^a   Grimm, Michael ^c   Müller, Mathias M ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Institute of Laboratory Diagnostics   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiac transplantation; Noninvasive monitoring; Serum amyloid A; Serum neopterin

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; NEOPTERIN; PREDNISOLONE; SERUM AMYLOID A; THYMOCYTE ANTIBODY;

ARTICLE; DIAGNOSTIC VALUE; GRAFT REJECTION; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; MONITORING; PRIORITY JOURNAL;

ANTILYMPHOCYTE SERUM; APOLIPOPROTEINS; AZATHIOPRINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; NEOPTERIN; SERUM AMYLOID A PROTEIN;

EID: 0345020370     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00100-4     Document Type: Article

References (31)

1. Kirett J.M., Kay M.I.P. The registry of the International Society for Heart Transplantation: seventh official report - 1990. J Heart Transplant. 9:1990;323-330.
2. Kobashigawa J, Naftel DC, Bourge RC, et al. Acute rejection after cardiac transplantation: A multiinstitutional analysis. J Heart Lung Transplant 1992;11:192.
3. Billingham M.E., Cary N.R.B., Hammond M.E.et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant. 9:1990;587-593.
4. Hunt S., Billingham M. Long-term results of cardiac transplantation. Annu Rev Med. 42:1991;437-447.
5. Sisson S., Jazzar A., Mischke L.et al. How many endomyocardial biopsies are necessary in the first year after heart transplantation? Transplant Int. 9:1996;243-247.
6. Burdick I.F., Kittur D.S. Factors affecting early diagnosis of organ allograft rejection. Transplant Proc. 23(4):1991;2047-2051.
7. Miller L.W. Long-term complications of cardiac transplantation. Prog Cardiovasc Dis. 33(4):1991;229-282.
8. Maury C.P.J., Teppo A.M. Comparative study of serum amyloid-related protein SAA, C-reactive protein and β2-microglobulin as markers of renal allograft rejection. Clin Nephrol. 22(6):1984;284-292.
9. Muller T.F., Schindler S., Sprenger H.et al. Prospective analysis of 10 different parameters of acute renal allograft rejection. Transplant Proc. 24(6):1992;2731-2734.
10. Fuchs D., Hausen A., Reibnegger G.et al. Neopterin as a marker for activated cell-mediated immunity. Immunol Today. 9(5):1988;150-155.
11. Muller M.M., Andert S.E., Winter P.M.et al. Laboratory diagnostics in organ transplantation. Lab Med. 14:1990;51-62.
12. Andert S.E., Grimm M., Schreiner W.et al. Therapeutic whole-blood levels of cyclosporin A in heart and lung transplantation. Clin Chim Acta. 224:1994;159-166.
13. Hocke G., Ebel H., Bittner K.et al. A rapid laser immunonephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection. Klin Wochenschr. 67:1989;447-451.
14. Rautenberg W., Heubner A., Neumann S. Kompetitiver enzymimmunoassay zur bestimmung von neopterin im humanserum [New competitive enzyme immunoassay for the determination of neopterin in human serum]. Klin Lab. 39:1993;503-510.
15. Hossein-Nia M.I., Brown P.A., Jennison S.H.et al. The use of CK-MB isoforms as a non-invasive marker of rejection following heart transplantation. Clin Chem. 38:1992;976.
16. Zimmermann R., Baki S., Dengler T.J.et al. Troponin T release after heart transplantation. Br Heart J. 69:1993;388-395.
17. Liuzzo G., Biasucci L.M., Gallimore J.R.et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331(7):1994;417-424.
18. Malle E., De Beer F.C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 26:1996;427-435.
19. Margreiter R., Fuchs D., Hausen A.et al. Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. Transplantation. 36:1983;650-653.
20. Woloszczuk W., Schwarz M., Havel M.I.et al. Neopterin and interferon gamma serum levels in patients with heart and kidney transplants. J Clin Chem Clin Biochem. 24:1986;729-734.
21. Holzel W.G.E., Havel M.I., Laczkovics A.et al. Diagnostic validity of multivariate combinations of biochemical analytes as markers for rejection and infection in the follow-up of patients with heart transplants. J Clin Chem Clin Biochem. 26:1988;667-671.
22. Schmitt F., Myara I., Benoit M.O.et al. Monitoring of heart allograft rejection by simultaneous measurement of serum beta-2 microglobulin and urinary neopterin. Ann Biol Clin (Paris). 47:1989;237-241.
23. Havel M.I., Laczkovics A., Teufelsbauer H.et al. Neopterin as a new marker to detect acute rejection after heart transplantation. J Heart Transplant. 8:1989;167-170.
24. Metsarinne K., Forslund T., Teppo A.M.et al. Increased plasma angiotensinogen in cardiac transplantation patients. Eur J Med. 2(6):1993;333-338.
25. Ogata F., Kohoda Y., Suzuki M.I.et al. High levels of serum amyloid A persist for a long time after kidney transplantation. Nephron. 55:1990;216-217.
26. Muller M.M., Andert S.E. Surveillance of therapy and monitoring of organ functions after transplantation. Diagnare & Labor. 44:1994;14-25.
27. Zuchelli G.C., Clerico A., de Maria R.et al. Increased circulating concentrations of interleukin-2 receptor during rejection episodes in heart- or kidney-transplant patients. Clin Chem. 36(12):1990;2106-2109.
28. Weyand M.I., Krehmeier M., Fahrenkamp A.et al. Serial interleukin-6 blood levels early after cardiac transplantation. Transplant Proc. 24(6):1992;2546.
29. Ferran C., Peuchmaur M., Desruennes M.I.et al. Implications of de novo ELAM-1 and VCAM-1 expression in human cardiac allograft rejection. Transplantation. 55:1993;605-609.
30. Koskinen P.K., Lemstrom K.B., Nieminen M.I.S.et al. Vascular cell adhesion molecule-1 (VCAM-1) is induced during cytomegalovirus infection in vascular structures of heart allografts. Transplant Int. 7(Suppl 1):1994;363-364.
31. Muller T.F., Sprenger H., Keuchel M.I.et al. Diagnosis of viral infections under therapy with OKT3 and antithymocyte globulin. Transplant Proc. 24(6):1992;2636-2638.